Literature DB >> 32285530

What it takes to recruit 77 subjects for a one-year study on active commuting.

Maria Dolores Fernandez La Puente de Battre1, Luis Moritz Neumeier2, Caroline Ensslin2, Martin Loidl3, Christoph Gräni4, Christian Schmied2, Bernhard Reich2, Josef Niebauer1, David Niederseer2.   

Abstract

Entities:  

Year:  2020        PMID： 32285530     DOI： 10.1111/sms.13682

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN： 0905-7188            Impact factor:   4.221


× No keyword cloud information.
  4 in total

1.  Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF).

Authors:  Helge Hebestreit; Susi Kriemler; Christian Schindler; Lothar Stein; Chantal Karila; Don S Urquhart; David M Orenstein; Larry C Lands; Jonathan Schaeff; Ernst Eber; Thomas Radtke
Journal:  Am J Respir Crit Care Med       Date:  2022-02-01       Impact factor: 21.405

2.  Effects of active commuting on cardiovascular risk factors: GISMO-a randomized controlled feasibility study.

Authors:  Bernhard Reich; David Niederseer; Martin Loidl; Maria Dolores Fernandez La Puente de Battre; Valentina Alice Rossi; Bernhard Zagel; Stefano Caselli; Christian Schmied; Josef Niebauer
Journal:  Scand J Med Sci Sports       Date:  2020-08       Impact factor: 4.221

3.  Effects of active commuting to work for 12 months on cardiovascular risk factors and body composition.

Authors:  Mahdi Sareban; Maria Dolores Fernandez La Puente de Battre; Bernhard Reich; Christian Schmied; Martin Loidl; David Niederseer; Josef Niebauer
Journal:  Scand J Med Sci Sports       Date:  2020-08       Impact factor: 4.221

4.  Health effects of active commuting to work: The available evidence before GISMO.

Authors:  Christine Schäfer; Barbara Mayr; Maria Dolores Fernandez La Puente de Battre; Bernhard Reich; Christian Schmied; Martin Loidl; David Niederseer; Josef Niebauer
Journal:  Scand J Med Sci Sports       Date:  2020-08       Impact factor: 4.221
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.